General MedicationsInjectionGeneric
BACITRACIN
BACITRACIN
Standard Dose
10,000 UNITS/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview BACITRACIN is listed in Drugs@FDA under application 062696 (ANDA).
Marketing status: Discontinued Active ingredient BACITRACIN Form and strength Injectable; Injection - 10,000 UNITS/VIAL Sponsor QUAD PHARMS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview BACITRACIN is listed in Drugs@FDA under application 062696 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN Form and strength Injectable; Injection - 10,000 UNITS/VIAL Sponsor QUAD PHARMS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.